TrivarX Limited (TRI.AX)
ASX · AUD · Healthcare · Health Information Services
A$0.008 (+0.00%) as of
Key statistics
- Market cap
- 9.23M
- EPS (TTM)
- -0.9600
- Dividend yield
- 0.00%
- 52-week range
- 0.0070 – 0.0315
- Beta
- 1.04
- Revenue (TTM)
- 14.57k
- Profit margin
- 0.00%
- Volume
- 188.42k
About TrivarX Limited
TrivarX Limited, a biotechnology company, engages in the development of AI-driven, and scientifically-based devices for screening and diagnosis of behavioral health conditions in Australia and the United States. It is also involved in research, development, and commercialisation of diagnostic and pharmaceutical products. The company was formerly known as Medibio Limited and changed its name to TrivarX Limited in October 2023. TrivarX Limited was incorporated in 1987 and is based in Hawthorn East, Australia.
- Sector
- Healthcare
- Industry
- Health Information Services
- Headquarters
- Hawthorn East, VIC, Australia
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.